Overview

Efficacy of Valproate in Peripheral Neuropathic Pain

Status:
Terminated
Trial end date:
2005-07-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether valproate is effective and well tolerated in the treatment of neuropathic peripheral pain. The drug is administered by intravenous route followed by oral route during 4 weeks.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Bordeaux
Collaborator:
Sanofi-Synthelabo
Treatments:
Valproic Acid
Criteria
Inclusion Criteria:

- peripheral neuropathic pain

- signed written informed consent

Exclusion Criteria:

- central neuropathic pain

- current or past hepatic disease